| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/10/2011 | US20110059951 HETEROCYCLIC DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 03/10/2011 | US20110059950 Aniline derivative having anti-rna viral activity |
| 03/10/2011 | US20110059949 Prophylaxis and treatment of infectious diseases |
| 03/10/2011 | US20110059948 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivatives as anti-mycobacterial agents |
| 03/10/2011 | US20110059947 Alpha 7 nicotinic agonists and antipsychotics |
| 03/10/2011 | US20110059946 Dual action antibiotics |
| 03/10/2011 | US20110059945 S1P Receptor Modulating Compounds and Use Thereof |
| 03/10/2011 | US20110059944 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 03/10/2011 | US20110059943 Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer |
| 03/10/2011 | US20110059942 Azetidinyl G-Protein Coupled Receptor Agonists |
| 03/10/2011 | US20110059941 2-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulators |
| 03/10/2011 | US20110059940 2-Aryl Glycinamide Derivatives |
| 03/10/2011 | US20110059939 Therapeutic compounds |
| 03/10/2011 | US20110059938 New chemical compounds |
| 03/10/2011 | US20110059937 Il-8 receptor antagonists |
| 03/10/2011 | US20110059936 C-met protein kinase inhibitors |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059934 Compounds and compositions useful for the treatment of parasitic diseases |
| 03/10/2011 | US20110059933 Crystalline sodium salt of cephalosporin antibiotic |
| 03/10/2011 | US20110059932 Liver x receptor agonists |
| 03/10/2011 | US20110059931 Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/10/2011 | US20110059930 Composition for the Regulation of the Human Immune System and the Prevention and Treatment of Diseases Thereof |
| 03/10/2011 | US20110059929 SUBSTITUTED BICYCLIC PIPERIDINYL-AND PIPERAZINYL- SULFONAMIDES USEFUL TO INHIBIT 11beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1 |
| 03/10/2011 | US20110059928 Graduated estrogen contraceptive |
| 03/10/2011 | US20110059927 Calcium Formate For Use As A Dietary Supplement |
| 03/10/2011 | US20110059926 Vitamin D Compounds and Methods for Reducing Ocular Hypertension (OHT) |
| 03/10/2011 | US20110059925 Methods for improving lid margin and tear film function and treatment of lid margin disease using tetracycline family antibiotics |
| 03/10/2011 | US20110059924 Chemoprevention of Colorectal Cancer by Mesalamine/Sulfasalazine |
| 03/10/2011 | US20110059923 Novel phosphate or a pharmaceutically acceptable salt thereof, a production method therefor and a pharmaceutical composition for preventing and treating central nervous system disorders containing the same as an active component |
| 03/10/2011 | US20110059922 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers |
| 03/10/2011 | US20110059921 Oligomer-Nitrogenous Base Conjugates |
| 03/10/2011 | US20110059920 Agent for regeneration and/or protection of nerves |
| 03/10/2011 | US20110059919 Antiviral composition comprising a sulfated polysaccharide |
| 03/10/2011 | US20110059918 Stable Hyaluronan/Steroid Formulation |
| 03/10/2011 | US20110059917 Vitamin d3 and analogs thereof for treating alopecia |
| 03/10/2011 | US20110059916 Methods and Compositions for Inducing Torpor in a Subject |
| 03/10/2011 | US20110059915 Purine derivatives and methods of use thereof |
| 03/10/2011 | US20110059913 Compositions and methods for the treatment of gastrointestinal indications |
| 03/10/2011 | US20110059912 Combination therapy comprising sglt inhibitors and dpp4 inhibitors |
| 03/10/2011 | US20110059911 Antiinfective and Antitumoral Compounds Isolated From Tropical Lianas |
| 03/10/2011 | US20110059910 Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds and the use thereof |
| 03/10/2011 | US20110059909 Methods for treating inflammatory disorders |
| 03/10/2011 | US20110059908 Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax |
| 03/10/2011 | US20110059907 Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care |
| 03/10/2011 | US20110059906 Energy status of an individual by enhanced production of an endogenous fuel source |
| 03/10/2011 | US20110059905 Methods of treating disease-induced ataxia and non-ataxic imbalance |
| 03/10/2011 | US20110059900 Diagnosing and treating hormone resistant cancers |
| 03/10/2011 | US20110059899 Kruppel-like factor 6 (KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein |
| 03/10/2011 | US20110059898 Pro-oxidant anti-cancer compounds |
| 03/10/2011 | US20110059896 Use of furin convertase inhibitors in the treatment of fibrosis and scarring |
| 03/10/2011 | US20110059895 Modulation of factor 9 expression |
| 03/10/2011 | US20110059893 Compounds for the treatment of proliferative disorders |
| 03/10/2011 | US20110059886 HCV NS3-NS4A Protease Inhibition |
| 03/10/2011 | US20110059885 Treatment of diseases and conditions mediated by eicosanoids |
| 03/10/2011 | US20110059531 Method for expression of small rna molecules within a cell |
| 03/10/2011 | US20110059516 Production of isoprenoids |
| 03/10/2011 | US20110059515 Production of isoprenoids |
| 03/10/2011 | US20110059187 Peptide dicer substrate agents and methods for their specific inhibition of gene expression |
| 03/10/2011 | US20110059183 Water-insoluble medicine |
| 03/10/2011 | US20110059181 Methods for drug delivery comprising unfolding and folding proteins and peptide nanoparticles |
| 03/10/2011 | US20110059180 Method for Preparing Nanoparticles Based on Functional Amphiphilic Molecules or Macromolecules, and the Use Thereof |
| 03/10/2011 | US20110059177 Cardioplegia Solution for Cardiac Surgery |
| 03/10/2011 | US20110059176 Material for preventing tissue adhesion and material for preventing joint contracture |
| 03/10/2011 | US20110059175 Enhancing solubility and dissolution rate of poorly soluble drugs |
| 03/10/2011 | US20110059174 PKCdelta REGULATES NEUROINFLAMMATORY EVENTS |
| 03/10/2011 | US20110059171 Oral galenic formulation including ketorolac and b-complex vitamins, in which vitamin b6 is in an outer layer separated from the rest of the active principles |
| 03/10/2011 | US20110059170 Methods for administering weight loss medications |
| 03/10/2011 | US20110059169 Method and Composition for Administering an NMDA Receptor Antagonist to a Subject |
| 03/10/2011 | US20110059164 Encapsulation of oxidatively unstable compounds |
| 03/10/2011 | US20110059162 Tannin-chitosan composites |
| 03/10/2011 | US20110059161 Targeted delivery using tissue-specific peptidomimetic ligands |
| 03/10/2011 | US20110059159 Nanoscale bound bilayers, methods of use and production |
| 03/10/2011 | US20110059158 Charged phospholipid compositions and methods for their use |
| 03/10/2011 | US20110059156 Nanostructures Suitable for Sequestering Cholesterol and Other Molecules |
| 03/10/2011 | US20110059154 Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same |
| 03/10/2011 | US20110059148 Flexible Drug Delivery Chip, its Fabrication Method and Uses Thereof |
| 03/10/2011 | US20110059141 Percutaneous absorption preparations of antidementia drugs |
| 03/10/2011 | US20110059139 Method for loading a molecule into a porous substrate |
| 03/10/2011 | US20110059136 Methods and Compositions for Treating Inflammatory Bowel Disease |
| 03/10/2011 | US20110059134 Prevention of recurrent viral disease |
| 03/10/2011 | US20110059125 Zwitterionic immunomodulators for the treatment of asthma and allergy |
| 03/10/2011 | US20110059123 Inhibition of the Survival of Colorectal Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 03/10/2011 | US20110059122 Inhibition of the Survival of Oral Cavity Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 03/10/2011 | US20110059120 Glucan-based vaccines |
| 03/10/2011 | US20110059118 Inhibitors of jak |
| 03/10/2011 | US20110059117 Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same |
| 03/10/2011 | US20110059114 Compositions and Methods for the Treatment of Radioresistant Glioma Stem Cells |
| 03/10/2011 | US20110059113 Gab2 amplification in melanoma |
| 03/10/2011 | US20110059111 Mammalian receptors as targets for antibody and active vaccination therapy against mold infections |
| 03/10/2011 | US20110059110 Antibody (11c7) anti nogo-a and its pharmaceutical use |
| 03/10/2011 | US20110059108 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 03/10/2011 | US20110059103 Future cardiac event biomarkers |
| 03/10/2011 | US20110059102 Therapeutic Method Targeting Midkine |
| 03/10/2011 | US20110059094 Antitumor effects of insulin-responsive dna binding protein-1 (irdbp-1) |
| 03/10/2011 | US20110059091 Inhibitors of oncogenic isoforms and uses thereof |
| 03/10/2011 | US20110059076 Human serum albumin linkers and conjugates thereof |
| 03/10/2011 | US20110059074 Knowledge-Based Proliferation Signatures and Methods of Use |
| 03/10/2011 | US20110059067 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides |
| 03/10/2011 | US20110059065 Function and regulation of adamts-1 |
| 03/10/2011 | US20110059051 Molecular Control of Brown Fat Differentiation and Engergy Expenditure |